Inflammation and atherogenic particle burden: Joint risk without proven synergy
Progress in Cardiovascular Diseases · 2026-09
DOI: 10.1016/j.pcad.2026.09.007 ↗Kurz gefasst
Editorial in der Zeitschrift Progress in Cardiovascular Diseases, 2026-09. Verfasst von Allan D Sniderman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre 1001 Decarie Blvd., Montrea…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre 1001 Decarie Blvd., Montreal, Quebec H4A 3J1, Canada.
- Midwest Biomedical Research, Addison, IL 60101, USA; Department of Applied Health Science, Indiana University School of Public Health-Bloomington, Bloomington, IN 47405, USA. Electronic address: kmaki@mbclinicalresearch…
Zitieren
APA
Sniderman, A. D., & Maki, K. C. (2026). Inflammation and atherogenic particle burden: Joint risk without proven synergy. Progress in Cardiovascular Diseases. https://doi.org/10.1016/j.pcad.2026.09.007
Vancouver
Sniderman AD, Maki KC. Inflammation and atherogenic particle burden: Joint risk without proven synergy. Progress in Cardiovascular Diseases. 2026. doi:10.1016/j.pcad.2026.09.007
BibTeX
@article{Sniderman2026,
author = {Sniderman, Allan D and Maki, Kevin C},
title = {Inflammation and atherogenic particle burden: Joint risk without proven synergy},
journal = {Progress in Cardiovascular Diseases},
year = {2026},
doi = {10.1016/j.pcad.2026.09.007}
}
EUVIMED